Poul H. B. Sorensen
British Columbia Cancer Research Centre
Department of Molecular Oncology
675 West Tenth Avenue
Vancouver
Canada
Name/email consistency: high
- Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Tognon, C.E., Sorensen, P.H. Expert Opin. Ther. Targets (2012)
- PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen, P.H., Lynch, J.C., Qualman, S.J., Tirabosco, R., Lim, J.F., Maurer, H.M., Bridge, J.A., Crist, W.M., Triche, T.J., Barr, F.G. J. Clin. Oncol. (2002)